Director of REMEDI
Development of gene and cell therapy approaches to vascular disease with a special focus on the augmentation of nitric oxide bioavailability.
Senior Lecturer in Regenerative Medicine
His key area of interest is translational medicine focusing on cardiovascular clinical trials for medical devices and basic science outputs.
Cardiovasular, Mesenchymal Stem Cells (MSCs), Angiogenic potential of microencapsulated MSCs
Karl's research looks at proteins associated with the dystrophin complex and he is also interested in growth and regeneration of muscle tissue.
Novel therapeutic approaches for the treatment of Multiple Sclerosis using (gene-modified) mesenchymal stem cells
Senior Lecturer in Medicine (Gene Therapy)
Cellular Immunology, Cornea Transplantation, Gene Therapy.